Table 2. Characteristic of subjects showing occult HCV.
| Patient | Sex | Age | ALT/AST* | HCV antibody | HCV-RNA plasma | HCV-RNA PBMCs | HCV Genotyping |
| 1 | M | 51 | −/− | − | − | + | 1a |
| 2 | M | 60 | −/− | − | − | + | n.d. |
| 3 | F | 46 | −/− | − | − | + | 1b |
| 4 | F | 52 | −/− | − | − | + | 1b |
| 5 | F | 56 | −/− | − | − | + | 2a |
| 6 | M | 41 | −/− | − | − | + | 2a |
| 7 | F | 54 | −/− | − | − | + | 2a |
| 8 | F | 55 | −/− | − | − | + | 1a |
| 9 | F | 47 | −/− | − | − | + | 1a |
*
: −/− indicates normal values below 50 IU/L and 35 IU/L for men and women respectively for ALT, and below 40 IU/L and 32 IU/L for men and women respectively for AST determination.
n.d.: the amplification resulting in a very weak fragment and sequence analysis did not succeed.